Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants

D Pastori, D Menichelli, F Del Sole, P Pignatelli… - Mayo Clinic …, 2021 - Elsevier
Objective To determine the association between direct oral anticoagulant (DOAC) use and
risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF). Patients …
被引用次数：28 相关文章

Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants.

D Pastori, D Menichelli, F Del Sole… - Mayo Clinic …, 2021 - go.gale.com
Objective: To determine the association between direct oral anticoagulant (DOAC) use and
risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF). Patients …

Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants

D Pastori, D Menichelli, F Del Sole… - Mayo Clinic …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To determine the association between direct oral anticoagulant (DOAC) use and
risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF). Patients …

Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants.

D Pastori, D Menichelli, F Del Sole… - Mayo Clinic …, 2020 - europepmc.org
Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral
Anticoagulants. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants

D Pastori, D Menichelli, F Del Sole… - MAYO CLINIC …, 2021 - iris.uniroma1.it
Objective: To determine the association between direct oral anticoagulant (DOAC) use and
risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF). Patients …

Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants

D Pastori, D Menichelli, F Del Sole… - Mayo Clinic …, 2021 - mayoclinicproceedings.org
Objective To determine the association between direct oral anticoagulant (DOAC) use and
risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF). Patients …